Description:
Procomil 5 mg is marketed as a tonic to address male sexual debility, sexual dysfunction, reduced libido, and related symptoms (e.g. fatigue, concentration loss) sometimes described as “male menopause” symptoms. 

Prescription:
Likely prescription-only (or pharmacy-only) in many jurisdictions, given the pharmacological activity and safety risks. (The product characteristics leaflet indicates “Prescriptions and pharmacy-only” status) 

Therapeutic Category:
Sexual / libido enhancer; aphrodisiac. It functions via pharmacological action on adrenergic receptors (via yohimbine). 

Active Ingredients / Composition:

• Yohimbine hydrochloride 5 mg per sugar-coated tablet. 
• Excipients: lactose, sucrose, glucose among others (these are listed in the product-characteristics document)

Variant:
Sugar-coated tablets; strength is 5 mg yohimbine. 

Consume Type:
Oral — tablets swallowed with water, after meals. 

Directions / Usage:

• Adults (male, ≥ 18 years): 1 to 2 tablets up to 3 times per day, yielding a maximum daily dose of 6 tablets (i.e. 30 mg yohimbine) 
• Treatment duration commonly about 8 weeks. 
• A latency period of 2–3 weeks is generally expected before onset of effect. 
• Tablets should be taken after meals with a glass of water. 
• Adjustments: use caution or lower doses in mild-to-moderate renal/hepatic impairment; contraindicated in severe impairment.

Common Side Effects:
From the summary of product characteristics:

• Common: headache, nausea, increased urination.
  
• Uncommon: vomiting, loss of appetite, stomach upset, diarrhea, palpitations, increased blood pressure or heart rate, dizziness, anxiety, restlessness, insomnia, sweating. 
• Very rare: hypotension, bronchospasm, allergic reactions, tremors, psychiatric disorders, etc.
  

Package Type:
Blister packs of sugar-coated tablets; original packaging often 30 tablets. 

Storage Advice:

• Store in a dry place at a temperature up to 30 °C. 
• Protect from sunlight. 
• Keep out of reach of children. (Standard practice)
  

Safety Advice / Precautions:

• Contraindications: hypersensitivity to yohimbine or excipients; heart disease (especially coronary artery disease, arrhythmias), uncontrolled hypertension or hypotension, severe renal or hepatic impairment, peptic ulcers, glaucoma, psychiatric disorders (mood/anxiety), concurrent use of certain CNS drugs. 
• Use caution and medical supervision if the patient has cardiovascular risk factors, or is using medications that affect blood pressure, CNS stimulants, antidepressants, etc. 
• Alcohol should not be consumed concomitantly. 
• Not indicated for women or children < 18 years.
• In cases of side effects, dose should be reduced or treatment discontinued. 
• Overdose symptoms: anxiety, confusion, tremors, tachycardia, hypertension, urinary retention, seizures.
  

Product Substitutes:
Other medicines containing yohimbine (if available in your region). Also, depending on the cause of erectile dysfunction or libido deficiency, other approved therapies (e.g. PDE-5 inhibitors) may serve as substitutes (as guided by physicians).

Manufacturer / Marketer:
Marketing authorisation holder is WALTER RITTER GmbH & Co. KG (Hamburg, Germany) according to the product summary sheet. 

Country of Origin:
Germany (as per the manufacturer)